We provide the latest news
from the world of economics and financeHere are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Medpace Holdings, Inc. MEDP: This clinical research-based drug and medical devices company has seen the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
CB Financial Services, Inc. CBFV: This bank holding company for Community Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 18.2% over the last 60 days.
Calix, Inc. CALX: This provider of cloud and software platforms has seen the Zacks Consensus Estimate for its current year earnings increasing 25.6% over the last 60 days.
LendingTree, Inc. TREE: This operator of an online consumer platform has seen the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.
Hasbro, Inc. HAS: This play and entertainment company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include
Stock #1: A Disruptive Force with Notable Growth and Resilience
Stock #2: Bullish Signs Signaling to Buy the Dip
Stock #3: One of the Most Compelling Investments in the Market
Stock #4: Leader In a Red-Hot Industry Poised for Growth
Stock #5: Modern Omni-Channel Platform Coiled to Spring
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.
Download Atomic Opportunity: Nuclear Energy's Comeback free today.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.